Skip to ContentSkip to Navigation
How to find us T.R. Eijgenraam, BSc

Publications

Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy (Scientific Reports, (2020), 10, 1, (9819), 10.1038/s41598-020-66656-9)

Current understanding of fibrosis in genetic cardiomyopathies

Strength of patient cohorts and biobanks for cardiomyopathy research

The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unreponsive to standard heart failure therapy

A novel method optimizing the normalization of cardiac parameters in small animal models: the importance of dimensional indexing

A novel phospholamban p.Arg14del cardiomyopathy mouse line treated with heart failure medication

Effect of long-term corticosteroid treatment on microRNA and gene-expression profiles in COPD

Generation and validation of a mouse model of the phospholamban p.Arg14del mutation

Read more